Cellectar Biosciences, Inc. (CLRB)
2.92
-0.09
(-2.99%)
USD |
NASDAQ |
Apr 17, 16:00
2.92
0.00 (0.00%)
After-Hours: 07:00
Cellectar Biosciences SG&A Expense (Quarterly) : 2.532M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| EyePoint, Inc. | 11.38M |
| Ocugen, Inc. | 6.132M |
| ACADIA Pharmaceuticals, Inc. | 155.62M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |
| Savara, Inc. | 12.53M |